Nitric Oxide and Cancer: Pathogenesis and Therapy Editat de Benjamin Bonavida iun 2015 Hardback Preț: 1103.75 lei 1161.85 lei 6-8 săpt. -5%
Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disorders: Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders Editat de Valentina Rapozzi et al. 18 noi 2024 Paperback Preț: 769.48 lei 1148.03 lei 5-7 săpt. -33%
Overcoming Cancers Resistant to HER-2 Antibodies Breaking Tolerance to Antibody-Mediated Immunotherapy, nr. 2 Editat de Benjamin Bonavida 17 iul 2024 Hardback Preț: 702.78 lei 879.40 lei 5-7 săpt. | 6-10 zile -20%
Nitric Oxide in Health and Disease: Therapeutic Applications in Cancer and Inflammatory Disorders Editat de Lucia Morbidelli et al. 17 apr 2023 Paperback Preț: 737.28 lei 1095.68 lei 5-7 săpt. | 6-10 zile -33%
YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target Editat de Benjamin Bonavida 19 oct 2020 Hardback Preț: 804.06 lei 1033.46 lei 5-7 săpt. -22%
Improving the Therapeutic Ratio in Head and Neck Cancer Cancer Sensitizing Agents for Chemotherapy, nr. 6 Benjamin Bonavida et al. 5 oct 2019 Hardback Preț: 792.80 lei 1033.57 lei 5-7 săpt. -23%
Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy Cancer Sensitizing Agents for Chemotherapy, nr. 5 Benjamin Bonavida et al. 8 mar 2019 Hardback Preț: 787.63 lei 1102.96 lei 5-7 săpt. -29%
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders Editat de Lucia Morbidelli et al. 13 feb 2019 Hardback Preț: 678.95 lei 944.96 lei 5-7 săpt. -28%
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy Cancer Sensitizing Agents for Chemotherapy, nr. 4 Benjamin Bonavida et al. 29 noi 2018 Hardback Preț: 824.44 lei 1031.61 lei 5-7 săpt. -20%
Role of Nutraceuticals in Cancer Chemosensitization Cancer Sensitizing Agents for Chemotherapy, nr. 2 Benjamin Bonavida et al. mai 2018 Hardback Preț: 823.21 lei 1026.95 lei 5-7 săpt. -20%
Nitric Oxide (Donor/Induced) in Chemosensitization Cancer Sensitizing Agents for Chemotherapy, nr. 1 Editat de Benjamin Bonavida 28 apr 2018 Hardback Preț: 816.50 lei 1022.89 lei 5-7 săpt. -20%
Targeting Cell Survival Pathways to Enhance Response to Chemotherapy Cancer Sensitizing Agents for Chemotherapy, nr. 3 Benjamin Bonavida et al. 28 mar 2018 Hardback Preț: 825.15 lei 1032.06 lei 5-7 săpt. -20%
Resistance to Immunotoxins in Cancer Therapy Resistance to Targeted Anti-Cancer Therapeutics, nr. 6 Editat de Rama Shanker Verma et al. 27 iun 2015 Hardback Preț: 721.19 lei 759.15 lei 6-8 săpt. -5%
Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance Resistance to Targeted Anti-Cancer Therapeutics, nr. 2 Editat de Benjamin Bonavida 5 aug 2013 Hardback Preț: 1093.88 lei 1151.45 lei 6-8 săpt. -5%
Resistance of Cancer Cells to CTL-Mediated Immunotherapy Resistance to Targeted Anti-Cancer Therapeutics, nr. 7 Editat de Benjamin Bonavida et al. 30 iun 2015 Hardback Preț: 726.68 lei 764.93 lei 6-8 săpt. -5%
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance Resistance to Targeted Anti-Cancer Therapeutics, nr. 1 Editat de Benjamin Bonavida 19 mai 2015 Paperback Preț: 1093.35 lei 1150.89 lei 6-8 săpt. -5%
Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy Cancer Drug Discovery and Development Editat de Benjamin Bonavida 5 sep 2012 Paperback Preț: 1422.50 lei 1497.36 lei 6-8 săpt. -5%
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy Cancer Drug Discovery and Development Editat de Benjamin Bonavida 25 iul 2008 Hardback Preț: 1433.10 lei 1508.52 lei 6-8 săpt. -5%
New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies Breaking Tolerance to Antibody-Mediated Immunotherapy Benjamin Bonavida 29 feb 2024 Hardback Preț: 703.31 lei 879.71 lei Nepublicat încă -20%
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance Editat de Benjamin Bonavida et al. 24 iun 2021 Hardback Preț: 685.11 lei 886.96 lei Indisponibil temporar -23%